Management of Chronic Myelocytic Leukemia in Pregnancy by Cell Pheresis
Authors:
- 2 January 1978
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 18 (1) , 120-124
Abstract
Cell pheresis was employed in the initial management of a pregnant patient with chronic myelocytic leukemia (CML). Reduction in circulating leukocyte and platelet counts was evident after two weeks of therapy. This technique is an effective mode of management of the pregnant patient with CIVIL and may play an important therapeutic role in the treatment of other myeloproliferative diseases characterized by dangerously high levels of circulating platelets or myeloblasts.Keywords
This publication has 21 references indexed in Scilit:
- Successful Control of Life‐Threatening Thrombocytosis with a Blood ProcessorTransfusion, 1975
- Leukapheresis of a Five‐Year‐Old Girl with Chronic Granulocytic LeukemiaTransfusion, 1975
- Chronic granulocytic leukaemia in pregnancyBritish Journal of Radiology, 1975
- Continuous Flow Centrifuge Leucapheresis in the Management of Chronic Myelogenous LeukaemiaBritish Journal of Haematology, 1975
- Busulfan treatment of leukemia during pregnancy. Case report and review of the literatureJAMA, 1967
- Busulfan in PregnancyJAMA, 1965
- Busulfan in PregnancyJAMA, 1962
- CONCEPTION AND PREGNANCY IN A PATIENT WITH CHRONIC MYELOCYTIC LEUKEMIA UNDER CONTINUOUS COLCEMIDE THERAPYAnnals of Internal Medicine, 1959
- Use of Busulfan in Myelogenous Leukemia during PregnancyNew England Journal of Medicine, 1958
- LEUKEMIA AND PREGNANCYJAMA, 1956